HHS has broken from the prior administration’s stance on artificial intelligence oversight, rejecting a private-sector vetting initiative known as the Coalition for Health AI, Politico reported.
CHAI is backed by companies including Microsoft and health systems including Rochester Minn.-based Mayo Clinic and Durham, N.C.-based Duke Health. Deputy HHS Secretary Jim O’Neill told the news outlet the department does not support the coalition and emphasized the group holds no regulatory authority.
“They don’t speak for us,” he told Politico, describing CHAI as a potential “cartel” that could pressure startups to join in order to compete. In a follow-up interview, he said he aimed to correct “the perception that this organization is a regulator, or a super pseudo regulator.”
CHAI, led by CEO Brian Anderson, MD, includes 3,000 members and has certified two assurance labs. The group has partnered with The Joint Commission to issue AI guidance. Anderson said CHAI’s work is voluntary and aimed at supporting informed policy decisions, not replacing formal regulation.
FDA Commissioner Marty Makary shares concerns about CHAI’s influence. The FDA, which regulates certain AI tools as medical devices, issued a request for information this week to gather input on how AI performance should be evaluated.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
